Avid Bioservices Inc (CDMO)

[swg_tdr]

AMAZING, geo? diff is the better management at Geron, but can anyone comment on their pipeline?

their only starting phase 2s, no "gamechanging results" so far that I can see, so what does WallStreet value in them, eh???

Imetelstat has demonstrated anti-tumor effects in a wide range of preclinical xenograft models of human solid and hematological tumors, and potent activity against cancer stem cells derived from primary patient samples or cancer cell lines from multiple tumor types.

Imetelstat has been tested in six Geron-sponsored Phase 1 clinical trials at 22 U.S. medical centers treating over 180 patients examining the safety, tolerability, pharmacokinetics and pharmacodynamics of the drug, alone or in combination with other standard therapies, in patients with different hematological and solid tumors.

Get rid of our BOD and Chairman, and our stock will be $10 instantly, IMHO

have a good day
NHwild